Page last updated: 2024-08-23

tetrahydrocannabivarin 9 and cannabidiol

tetrahydrocannabivarin 9 has been researched along with cannabidiol in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (11.11)29.6817
2010's8 (88.89)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pertwee, RG1
Amada, N; Arthur, M; Close, S; Deiana, S; Dorward, P; Fleming, S; Pigliacampo, B; Platt, B; Riedel, G; Watanabe, A; Woodcock, H; Yamasaki, Y1
Dashney, B; Limebeer, CL; O'Brien, LD; Parker, LA; Rock, EM; Segsworth, B; Wills, KL1
Di Marzo, V; Duncan, M; McPartland, JM; Pertwee, RG1
Cawthorne, M; Di Marzo, V; Guadagnino, I; Martella, A; Melck, D; Motta, A; Paris, D; Silvestri, C1
Barnes, AJ; Huestis, MA; Newmeyer, MN; Scheidweiler, KB1
Barrett, DA; Bell, JD; Jadoon, KA; O'Sullivan, SE; Ratcliffe, SH; Stott, C; Tan, GD; Thomas, EL1
Friedman, D; Gaston, TE1
Di Marzo, V; Izzo, AA; Lauritano, A; Pagano, E; Piscitelli, F1

Reviews

3 review(s) available for tetrahydrocannabivarin 9 and cannabidiol

ArticleYear
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.
    British journal of pharmacology, 2008, Volume: 153, Issue:2

    Topics: Animals; Cannabidiol; Dronabinol; Drug Tolerance; Humans; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Synaptic Transmission

2008
Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review.
    British journal of pharmacology, 2015, Volume: 172, Issue:3

    Topics: Animals; Cannabidiol; Cannabinoid Receptor Modulators; Dronabinol; Endocannabinoids; Humans; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2

2015
Pharmacology of cannabinoids in the treatment of epilepsy.
    Epilepsy & behavior : E&B, 2017, Volume: 70, Issue:Pt B

    Topics: Animals; Anticonvulsants; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Drug Combinations; Epilepsy; Humans; Receptor, Cannabinoid, CB1; Treatment Outcome

2017

Trials

1 trial(s) available for tetrahydrocannabivarin 9 and cannabidiol

ArticleYear
Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study.
    Diabetes care, 2016, Volume: 39, Issue:10

    Topics: Aged; Blood Glucose; Body Mass Index; Body Weight; Cannabidiol; Cholesterol; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Endpoint Determination; Female; Gastric Inhibitory Polypeptide; Glycated Hemoglobin; Humans; Male; Middle Aged; Pilot Projects; Triglycerides

2016

Other Studies

5 other study(ies) available for tetrahydrocannabivarin 9 and cannabidiol

ArticleYear
Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ⁹-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behavi
    Psychopharmacology, 2012, Volume: 219, Issue:3

    Topics: Administration, Oral; Animals; Cannabidiol; Cannabinoids; Compulsive Behavior; Dronabinol; Injections, Intraperitoneal; Male; Mice; Obsessive Behavior; Rats; Rats, Wistar

2012
Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behavior and saccharin palatability.
    Pharmacology, biochemistry, and behavior, 2013, Volume: 103, Issue:3

    Topics: Animals; Anxiety; Behavior, Animal; Cannabidiol; Cannabinoid Receptor Antagonists; Cannabinoids; Disease Models, Animal; Dronabinol; Drug Administration Schedule; Drug Inverse Agonism; Male; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Rimonabant; Saccharin; Taste; Taste Perception

2013
Two non-psychoactive cannabinoids reduce intracellular lipid levels and inhibit hepatosteatosis.
    Journal of hepatology, 2015, Volume: 62, Issue:6

    Topics: 3T3-L1 Cells; Adipocytes; Animals; Cannabidiol; Cannabinoids; Cell Line; Dronabinol; Hepatocytes; Humans; Lipid Metabolism; Mice; Mice, Obese; Non-alcoholic Fatty Liver Disease; Oleic Acid; Receptor, Cannabinoid, CB1; Triglycerides; TRPV Cation Channels; Zebrafish

2015
Quantification of cannabinoids and their free and glucuronide metabolites in whole blood by disposable pipette extraction and liquid chromatography-tandem mass spectrometry.
    Journal of chromatography. A, 2016, Jul-01, Volume: 1453

    Topics: Biomarkers; Cannabidiol; Cannabinoids; Chromatography, Liquid; Dronabinol; Glucuronides; Humans; Marijuana Smoking; Substance Abuse Detection; Tandem Mass Spectrometry

2016
Development of a Rapid LC-MS/MS Method for the Quantification of Cannabidiol, Cannabidivarin, Δ
    Analytical chemistry, 2017, 04-18, Volume: 89, Issue:8

    Topics: Animals; Cannabidiol; Cannabinoids; Chromatography, High Pressure Liquid; Colitis; Colon; Dronabinol; Limit of Detection; Male; Mice; Mice, Inbred ICR; Pancreas; Tandem Mass Spectrometry

2017
chemdatabank.com